Loading
Cancer Research and Treatment / Pancreatic Function and Diabetes · Journal article
Theoretical and Natural Science · August 17, 2026
A consensus or society position rather than new primary data.
This is a narrative literature review that summarizes clinical development, technical principles, and experimental results of various cell therapy approaches for diabetes mellitus. It does not present primary evidence, randomized trial data, or quantified efficacy outcomes, but rather provides a reference framework comparing advantages and disadvantages of different methods and identifying future development trends.
Journal article. Patients with diabetes mellitus, in the context of rising global prevalence associated with obesity and population aging..
Cell-based therapy can substitute for islet function and achieve long-term glycemic regulation, in contrast to current pharmacological and insulin replacement therapies which control blood glucose but cannot repair pancreatic islet β-cell functional defects or cure the disease.
No quantified efficacy, safety, or comparative outcome data are provided. Cell-based therapy can substitute for islet function and achieve long-term glycemic regulation, in contrast to current pharmacological and insulin replacement therapies which control blood glucose but cannot repair pancreatic islet β-cell functional defects or cure the disease.
This review provides a synthesis of the field rather than actionable clinical evidence. Clinicians and researchers should consult it for an overview of cell therapy landscape and future directions, but should refer to primary trials for efficacy and safety data to guide clinical decisions.
A literature review summarizing clinical development, technical principles, and experimental results of cell therapy approaches for diabetes, offering a reference for research and clinical translation rather than reporting primary evidence.
This review provides a synthesis of the field rather than actionable clinical evidence. Clinicians and researchers should consult it for an overview of cell therapy landscape and future directions, but should refer to primary trials for efficacy and safety data to guide clinical decisions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
With the rising global prevalence of obesity and population aging, the number of patients with diabetes mellitus, a common chronic metabolic disorder, keeps rising and imposes mounting pressure on clinical medical services. Although current pharmacological interventions and insulin replacement therapy can effectively control blood glucose levels, they cannot fundamentally repair the functional defects of pancreatic islet β-cells, nor can they cure the disease. Under these circumstances, cell-based therapy has gradually become a research hotspot in the field of biomedical science in recent years, as it can substitute for islet function and thereby achieve long-term glycemic regulation. This article summarizes the clinical development, technical principles, and experimental results of various approaches, and compares the advantages and disadvantages of different methods. Meanwhile, this paper discusses the shortcomings of cell therapy at the present stage. On this basis, the future development trends of diabetes cell therapy are predicted, providing a reference for subsequent research and clinical translation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.